Johnson & Johnson told to pay $2.1bn over cancer-causing talcum powder

Published June 24, 2020
J&J has faced thousands of lawsuits across the US alleging it failed to warn consumers of the risk of cancer from asbestos in its talc-based products. — Reuters/File
J&J has faced thousands of lawsuits across the US alleging it failed to warn consumers of the risk of cancer from asbestos in its talc-based products. — Reuters/File

A United States court has upheld a verdict that talcum powder sold by Johnson & Johnson caused ovarian cancer and ordered the pharmaceutical giant to pay $2.1 billion in damages.

The decision by the Missouri Court of Appeals cut by more than half the $4.4bn a jury had awarded 22 people in 2018. The court agreed that some of the plaintiffs should not have been included in the case as they were from outside the state.

But the Tuesday decision upheld the awarding of damages for the company “knowingly selling products that contained asbestos to consumers".

“Because defendants are large, multi-billion-dollar corporations, we believe a large amount of punitive damages is necessary to have an effect in this case,” the judgement said.

“It is impossible to place monetary value on the physical, mental and emotional anguish plaintiffs suffered because of their injury caused by defendants.”

A spokeswoman for J&J said the company would appeal the decision in the Supreme Court of Missouri, according to the Wall Street Journal.

J&J has faced thousands of lawsuits across the US alleging it failed to warn consumers of the risk of cancer from asbestos in its talc-based products.

In 2019, a California jury became the latest to award millions in damages to a plaintiff who said the company's baby powder had given her terminal cancer.

Last month, the firm announced it was discontinuing production of its talc-based baby powder in the US and Canada, in part due to the “constant barrage of litigation advertising” over the product.

It will continue to sell the product in the rest of the world, it added.

Opinion

Editorial

Military option
Updated 21 Nov, 2024

Military option

While restoring peace is essential, addressing Balochistan’s socioeconomic deprivation is equally important.
HIV/AIDS disaster
21 Nov, 2024

HIV/AIDS disaster

A TORTUROUS sense of déjà vu is attached to the latest health fiasco at Multan’s Nishtar Hospital. The largest...
Dubious pardon
21 Nov, 2024

Dubious pardon

IT is disturbing how a crime as grave as custodial death has culminated in an out-of-court ‘settlement’. The...
Islamabad protest
Updated 20 Nov, 2024

Islamabad protest

As Nov 24 draws nearer, both the PTI and the Islamabad administration must remain wary and keep within the limits of reason and the law.
PIA uncertainty
20 Nov, 2024

PIA uncertainty

THE failed attempt to privatise the national flag carrier late last month has led to a fierce debate around the...
T20 disappointment
20 Nov, 2024

T20 disappointment

AFTER experiencing the historic high of the One-day International series triumph against Australia, Pakistan came...